More referrals does not equal more progress and I see this play out in almost every sponsor conversation I have. Our team just surveyed 100 U.S. clinical trial site professionals, and the numbers back up what a lot of us feel anecdotally: 52% say at least 1 in 5 referrals get ruled ineligible before formal screening even starts. And 62% of the time, it's because the patient never met inclusion/exclusion criteria in the first place. Volume was never the hard part. Readiness is and patients showing up qualified, documented, and actually able to move through enrollment. That's the piece sites are still missing, and it's exactly the gap we built our pre-screening approach to close. Proud of the myTomorrows team for putting real numbers behind this. The Referral Readiness Gap covers the hidden workload, fragmented systems, and what site teams say would actually help. To learn more about how myTomorrows is changing the landscape for patient recruitment please DM or email me at kevin.harkey@mytomorrows.com #clinicaltrials #AI #patientrecruitment #pharmaceuticals #Biotechnology #oncology #neurology #clinicalresearch #mytomorrows

As a doctor who now works in UX research at myTomorrows, the new report finding that stayed with me isn't that 1 in 5 referrals get ruled ineligible, but the why behind it. Part of the problem starts upstream of the site entirely. Many referrals are identifiable as ineligible before they ever reach a coordinator's desk. Worth a read if referral quality, site workload, or trial recruitment touch any part of your work:

It's been a delight to work on the newst myTomorrows data research report - this time looking at the true experiences impacting clinical researchers every day. To find out what is causing at least 1 in 5 referrals to be ineligible before formal screening - check out the report ➡️ https://mytomorro.ws/r7s

Much of the current conversation around clinical trial recruitment focuses on generating more referrals. Our survey of 100 clinical trial site professionals highlights a different challenge: they need better qualified ones. → 27% of sites spend 20+ hours a week just reviewing incoming referrals.  → 52% use at least four different tools for pre-screening alone. The findings suggest that recruitment challenges are no longer just about referral volume. Sites need patients who are informed, qualified, and ready to move through enrollment. Improving clinical trial access starts with listening to sites and building toward solutions, like AI-supported pre-screening and patient navigation that reduce friction in recruitment, rather than add to it. 📖 Read the full findings: → blog: [https://mytomorro.ws/820] → report: [https://mytomorro.ws/bgf] #ClinicalTrials #ClinicalResearch #PatientAccess #PatientRecruitment 

More referrals do not always help research sites. Better-qualified referrals do. When sites receive patients who are unlikely to qualify, everyone loses time. Sites face more screen failures. Patients experience more frustration. Sponsors see more enrollment risk. And timelines become harder to predict. At CTM, we combine high-tech precision with high-touch engagement to help sponsors identify, pre-screen, and support patients more effectively. Because the goal is not just more patient interest, it is more of the right patients, better supported, through study completion. What would help research sites most? 🔹 Better-qualified & engaged referrals 🔹 Fewer screen failures 🔹 Stronger patient follow-through 🔹 Less admin #ClinicalTrials #PatientRecruitment #SiteSuccess #ClinicalOperations #ClinicalResearch

If patient enrollment is behind, is adding more sites really the next best move? It feels like action.  It looks like progress.  But it's the most expensive way to scale the problem instead of solving it. A new site averages about eight months to open and $20,000 to $30,000 to stand up, before it enrolls anyone. (Tufts CSDD, 2018) Sponsors add sites because spreading wide feels safer than concentrating effort. But volume only buys speed when the shortfall is a capacity problem. When it isn't, a bigger network reaches the same finish line, later, for more money. Before the next contract, ask: "Is this a site problem or a market fit problem?" Discover today why additional sites doesn't mean faster recruitment: https://hubs.ly/Q04p8T_d0 #ClinicalTrialRecruitment #PatientRecruitment #ClinicalTrials #ClinicalResearch

Feeling the pressure of patient recruitment? You're not alone. The right patients can make or break your study, but finding them doesn’t have to be a struggle. TheraNovex streamlines the entire recruitment process — from outreach to retention. Say goodbye to low-quality leads and enrollment delays. It’s time to transform patient interest into real study participation. Discover how to make patient recruitment a breeze. https://theranovex.com #clinicaltrials #patientengagement #researchrecruitment #studyparticipation #clinicaloperations

Patient recruitment is more crucial than ever. With increasing competition for qualified participants, the right strategy can set your clinical trial apart. Imagine transforming interested patients into committed participants effortlessly. TheraNovex is here to help streamline your recruitment process, reduce friction, and enhance your engagement. Don't let your study fall behind. Discover how we can elevate your patient recruitment game today! https://theranovex.com #clinicaltrials #patientrecruitment #clinicalresearch #healthcareinnovation #patientengagement

Our team investigated referral quality in clinical trial recruitment. The result: The Referral Readiness Gap, based on a survey of 100 U.S. site professionals in May 2026. Key findings of the report show the ineffective referral flow for sites: 💚 52% say at least 1 in 5 referrals are ruled ineligible before formal screening begins. 💚 62% say because patients don't meet the inclusion criteria There are more key take aways that in my opinion are similar in Europe. For example, European sites often mention the burden of hours spent manually reviewing referrals that turn out to be ineligible. This is time that can be used better and should be returned to direct care of patients. ⏱️ 27% of sites spend 20+ hours per week reviewing incoming referrals. 🔄 47% say triage takes 10–30 minutes per patient. 🩺 50% say recruitment workload sometimes limits their ability to focus on patient care or study quality. Access the full report here: https://mytomorro.ws/ttv And find our blog here: https://mytomorro.ws/0z6 . . . . #ClinicalTrials #ClinicalResearch #PatientAccess #TrialRecruitment #myTomorrows #NHS

In one study, patients without Patient Navigator support were 2x more likely to discontinue. That's the impact of real conversations, personalized guidance, and 1:1 support throughout the trial journey. #clinicaltrials #patientretention